This law firm has not supplied any contact details or supplementary information for this country or region. For more information about profiling options please contact Prin Shasiharan.
2025 Edition
Outstanding
Highly recommended
Recommended
Notable
Overview
Founded in 2013, PI IP Law is an intellectual property specialist firm with a focus on software and artificial intelligence (AI). Its burgeoning reputation in the technology sphere has powered its impressive roster of startup clients, many trusting the firm with their patent-rich portfolios. The firm covers the full spectrum of IP services for its clients, including trademark and patent prosecution, design and litigation. Some of its clients are leaders in the medical AI, smart factory and natural language processing markets. Managing partner Daeho Lee is the executive director of the Korea AI Association and actively provides insights on AI-related IP policies with the government and affiliated research institutions. PI IP Law has its own affiliate IT startup, Sejinmind, which digitises the legal solutions it provides.
Client feedback
"Smooth procedures." – Intellectual property
"Particularly specialised in the AI space, and their understanding and experience in this field are second to none in Korea." – Intellectual property
"PI IP Law is very experienced and knowledgeable in the areas of trademark and patent prosecution and strategy." – Intellectual property
"The firm is responsive and dedicated to its work. We never hesitate to recommend them to other firms." – Intellectual property
Jaeyoon Kim
"Excellent and deep knowledge in the AI space."
Daeho Lee
"In-depth knowledge and experience in trademark prosecution and strategy."
Gunhong Park
"He is responsive and hard-working."
Linked Reviews
Intellectual property (asialaw)
Work highlights
Advised NeogenTC on expanding their intellectual property portfolio through an IP scale-up project, focusing on immune cell therapy technologies. The year-long collaboration resulted in 30 patent applications, with a 95% registration rate in South Korea, covering innovative ideas in tumour-infiltrating lymphocyte cell therapy and T-cell receptor (TCR) modified T-cell therapy. The project involved integrating AI expertise with bioscience knowledge, leading to high-quality patent applications in neoantigen and TCR technology fields, and fostering efficient R&D direction while securing exclusive rights.
Key clients
MakinaRocks, Vive Studios, VRCREW